Pakola, S. A., Ojala, N., Kudling, T. V., Clubb, J. H. A., Jirovec, E., Heijden, M. v. d., . . . Hemminki, A. Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. Springer.
Chicago Style (17th ed.) CitationPakola, Santeri A., et al. Oncolytic Adenovirus Encoding Variant Interleukin-2 Combined with Chemotherapy Enables PD-L1 Inhibition in Pancreatic Cancer Models. Springer.
MLA (9th ed.) CitationPakola, Santeri A., et al. Oncolytic Adenovirus Encoding Variant Interleukin-2 Combined with Chemotherapy Enables PD-L1 Inhibition in Pancreatic Cancer Models. Springer.
Warning: These citations may not always be 100% accurate.